Maze Therapeutics Doses First Patient in Phase 2 HORIZON Clinical Trial Evaluating MZE829 as a Potential Treatment for APOL1 Kidney Disease
Maze Therapeutics, Inc. (Nasdaq: MAZE), a clinical-stage biopharmaceutical company harnessing the power of human genetics to ...
Maze Therapeutics begins Phase 2 trial for kidney disease drug
Maze Therapeutics, Inc. (NASDAQ: MAZE), a clinical-stage biopharmaceutical company with a market capitalization of $569 million, has dosed the first patient in its Phase 2 HORIZON Study of MZE829, ...
TikTok Has A Simple Exit From U.S. Ban Maze
With Trump back in charge, a long list of mooted, familiar buyers is re-emerging. The simplest way to scroll past this glitch ...
FierceBiotech11d
Maze rolls out map to $131M IPO, as phase 2 kidney disease trial readies for dosing
Maze Therapeutics has set out plans for a $131 million IPO as the company prepares to start dosing its lead kidney drug in a ...
University of California1d
Researchers solve a fluid mechanics mystery
UC Santa Barbara researchers now know why a pool of red dye somehow “knew” how to solve a maze filled with milk.
MinnPost9d
Is Minnesota home to the largest ice maze in the world?
Until this year, the Guinness World Record was held by a nearly 13,000-square-foot ice labyrinth in New York that took the ...
Wes Ball, Joe Hartwick And Their OddBall Entertainment Ink With CAA
EXCLUSIVE: The Maze Runner filmmakers and their OddBall Entertainment studio have signed with CAA, we can tell you. Wes Ball ...